Elsevier

Neuropharmacology

Volume 56, Issue 4, March 2009, Pages 798-807
Neuropharmacology

Induction of Fos proteins in regions of the nucleus accumbens and ventrolateral striatum correlates with catalepsy and stereotypic behaviours induced by morphine

https://doi.org/10.1016/j.neuropharm.2009.01.003Get rights and content

Abstract

A history of intermittent exposures to drugs of abuse can cause long-term changes in acute behavioural responses to a subsequent drug exposure. In drug-naive rats, morphine can elicit intermittent cataleptic postures followed by sustained increases in locomotor activity. Chronic intermittent morphine treatment can reduce catalepsy and increase locomotor behaviour and stereotypy induced by morphine, even after prolonged periods of abstinence. The nucleus accumbens and limbic basal ganglia circuitry are implicated in the expression of various morphine-induced motor behaviours and catalepsy. We examined the effect of intermittent morphine exposure on the distribution of Fos proteins in the basal ganglia following a subsequent morphine challenge administered after a period of drug abstinence. We found that such exposures increased c-Fos induced by a morphine challenge in accumbens core regions that were immunoreactive for the μ-opioid receptor, and this correlated with the frequency of stereotypic behaviours displayed by the rats. We also found that a history of morphine exposures increased c-Fos in the ventrolateral striatum in response to a morphine challenge following 14 d but not 24 h of drug abstinence. In contrast, such a history induced acute Fras in the nucleus accumbens in response to a morphine challenge following 24 h but not 14 d of morphine abstinence. These data provide further confirmation that psychomotor sensitisation induced by repetitive morphine exposure involves long-term neuroadaptations in basal ganglia circuitry particularly at the level of the nucleus accumbens.

Introduction

Intermittent exposures to drugs of abuse typically cause long-term changes in the acute behavioural responses elicited by later re-exposure to the drug following a period of abstinence. The mechanisms underlying these changes have been studied extensively as not only do they contribute to drug tolerance and sensitisation, but they are also generally thought to contribute to the development and maintenance of drug addiction.

Opiates (e.g., morphine) can affect motor behaviours and locomotor activity when administered to drug-naive subjects (Bechara and van der Kooy, 1992, Leite-Morris et al., 2002, Vasko and Domino, 1978). The pattern of responding varies according to species, agonist properties and drug–dose; but most typically, an early phase of inhibition is followed by a longer period of facilitation. For example, in drug-naive rats higher doses of morphine initially inhibit locomotor activity or elicit intermittent cataleptic postures (Brown et al., 1983, De Ryck et al., 1980, Olmstead and Franklin, 1994, Wilcox et al., 1983), but this is followed by sustained increases in locomotor activity (Bechara and van der Kooy, 1992, Leite-Morris et al., 2002, Vasko and Domino, 1978). This pattern of behaviour changes when rats have previously received intermittent morphine administrations. The incidence of catalepsy is reduced (Cadoni and Di Chiara, 1999, Hand and Franklin, 1985), and opioid-induced stereotypy is facilitated (Cadoni and Di Chiara, 1999, Powell and Holtzman, 2001, Ranaldi et al., 2000, Vanderschuren et al., 2001, Vanderschuren et al., 1997, Vasko and Domino, 1978, Vezina and Stewart, 1989). Once established, these alterations in opioid-induced behaviours can be maintained for periods of many weeks or months in the absence of the drug (Powell and Holtzman, 2001).

Regulation of gene expression following opiate induction of psychomotor changes has been detected by measuring changes in the expression of Fos family transcription factors in the basal ganglia circuitry (D'Este et al., 2002, Erdtmann-Vourliotis et al., 1999, Moratalla et al., 1996, Vanderschuren et al., 2002). Two basic types of response have been reported by a majority of studies: down regulation of c-Fos, and up-regulation of ΔFosB, a stable product of FosB that accumulates in the nucleus accumbens during chronic drug administration and continues to be expressed following weeks of abstinence. On the basis of this and other evidence, Nestler and colleagues have identified induction of ΔFosB as a potential cellular mechanism that underlying the development of addictive behaviour (Nestler et al., 1999, Nestler et al., 2001).

Many studies have reported that c-Fos mRNA and protein are induced in the nucleus accumbens when drug-naïve rats are injected with morphine (Barrot et al., 1999, Bontempi and Sharp, 1997, Curran et al., 1996, D'Este et al., 2002, Garcia et al., 1995, Liu et al., 1994, Nye and Nestler, 1996, Sharp et al., 1995). Chronic morphine-pelleted rats show a progressive increase in the expression of ΔFosB in the accumbens (Nye and Nestler, 1996). Changes in c-Fos mRNA and protein have also been identified following acute morphine in drug-sensitised rats in cortex, thalamus, and dorsal striatum (Curran et al., 1996, Erdtmann-Vourliotis et al., 1999, Frankel et al., 1999). However, few studies have reported changes in the accumbens, and while D'Este et al. (2002) found that c-Fos protein was decreased in the accumbens shell in heroin-sensitised rats, Curran et al. (1996) found c-Fos mRNA was increased in the caudal accumbens in morphine-sensitised rats. On the basis of these conflicting findings, the present study has examined the effect of intermittent morphine exposure on the distribution of Fos proteins in the striatal complex when rats were later challenged with morphine after a period of drug abstinence. We found evidence of a positive correlation between morphine-induced stereotyped behaviour and numbers of c-Fos-positive neurons in specific regions of the striatum and nucleus accumbens. We also identified a population of neurons in the nucleus accumbens, which express Fos family proteins but do not express c-Fos, when morphine is administered after a short 24 h period of abstinence following previous intermittent morphine exposures.

Section snippets

Animals

Fifty-six experimentally naive, male Wistar rats (300–400 g) were obtained from a commercial supplier (Gore Hill Laboratories, Sydney, Australia) and used as subjects. After arrival, rats were housed in groups of four or eight in plastic boxes (40 × 65 cm, and 32 cm high) maintained on a 12 h light–dark cycle (lights on at 07:00 h). Food and water were continuously available. All procedures using these animals were approved by the Animal Care and Ethics Committee of the University of New South

Morphine pretreatment increases c-Fos neurons in the ventrolateral striatum after a morphine challenge

Video recordings were used to score the frequency of cataleptic postures, stereotyped (confined gnawing, sniffing, grooming) and non-stereotyped (forward locomotor activity, rearing) behaviours, and sleep. The experiment compared groups of rats that were pretreated for 14 d with daily injections of saline or escalating doses of morphine. After a 14 d abstinence period each group was then split into two further groups that were challenged with either saline or morphine at test. No significant

Discussion

The major finding of the present study was that pretreatment with morphine followed by a period of abstinence increased c-Fos induced by a morphine challenge in the accumbens core patches with high levels of μ-opioid (MOP) receptor immunoreactivity, and this was correlated with stereotypic behaviours displayed by the rats. Moreover, c-Fos in regions of the accumbens core matrix with low MOP receptor immunoreactivity was reduced by morphine pretreatment. We also found that morphine pretreatment

References (46)

  • K.A. Leite-Morris et al.

    Opiate-induced motor stimulation is regulated by gamma-aminobutyric acid type B receptors found in the ventral tegmental area in mice

    Neurosci. Lett.

    (2002)
  • A. Mansour et al.

    Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS

    J. Chem. Neuroanat.

    (1995)
  • R. Moratalla et al.

    Network-level changes in expression of inducible Fos–Jun proteins in the striatum during chronic cocaine treatment and withdrawal

    Neuron

    (1996)
  • E.J. Nestler et al.

    DeltaFosB: a molecular mediator of long-term neural and behavioral plasticity

    Brain Res.

    (1999)
  • M.C. Olmstead et al.

    Lesions of the pedunculopontine tegmental nucleus abolish catalepsy and locomotor depression induced by morphine

    Brain Res.

    (1994)
  • P.B. Osborne et al.

    Localization of immunoreactivity for DCC, the receptor for the guidance factor netrin-1, in ventral tier dopamine projection pathways in adult rodents

    Neuroscience

    (2005)
  • M. Pisa

    Regional specialization of motor functions in the rat striatum: implications for the treatment of parkinsonism

    Prog. Neuropsychopharmacol. Biol. Psychiatr.

    (1988)
  • K.R. Powell et al.

    Parametric evaluation of the development of sensitization to the effects of morphine on locomotor activity

    Drug Alcohol Depend.

    (2001)
  • F.R. Sharp et al.

    NMDA and D1 receptors mediate induction of c-fos and junB genes in striatum following morphine administration: implications for studies of memory

    Behav. Brain Res.

    (1995)
  • J. Taylor et al.

    Metamizol potentiates morphine effects on visceral pain and evoked c-Fos immunoreactivity in spinal cord

    Eur. J. Pharmacol.

    (1998)
  • P. Vezina et al.

    The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine

    Brain Res.

    (1989)
  • Q.P. Wang et al.

    Endomorphin-2 immunoreactivity in the cervical dorsal horn of the rat spinal cord at the electron microscopic level

    Neuroscience

    (2002)
  • R.E. Wilcox et al.

    Reversal of morphine-induced catalepsy by naloxone microinjections into brain regions with high opiate receptor binding: a preliminary report

    Pharmacol. Biochem. Behav.

    (1983)
  • Cited by (0)

    View full text